BeOne Medicines
ONC
#542
Rank
$46.48 B
Marketcap
$406.96
Share price
5.09%
Change (1 day)
23.62%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2023 (TTM): -$16.64

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is $5.98. In 2022 the company made an earnings per share (EPS) of -$19.37 a decrease over its 2021 EPS that were of -$15.21.

EPS history for BeOne Medicines from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$16.64-14.09%
2022-$19.3727.35%
2021-$15.21-19.96%
2020-$19.0020.81%
2019-$15.7331.52%
2018-$11.96417.57%
2017-$2.31-37.16%
2016-$3.68158.95%
2015-$1.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-$0.09000-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$0.95-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA